Griffin Asset Management Inc. Has $9.86 Million Stake in Danaher Corporation $DHR

Griffin Asset Management Inc. trimmed its stake in Danaher Corporation (NYSE:DHR) by 1.6% in the second quarter, HoldingsChannel.com reports. The firm owned 49,889 shares of the conglomerate’s stock after selling 791 shares during the period. Danaher accounts for about 1.2% of Griffin Asset Management Inc.’s investment portfolio, making the stock its 29th largest holding. Griffin Asset Management Inc.’s holdings in Danaher were worth $9,855,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. MGO One Seven LLC boosted its position in Danaher by 485.7% during the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock valued at $5,145,000 after acquiring an additional 20,813 shares during the last quarter. Chicago Capital LLC boosted its position in Danaher by 11.6% during the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock valued at $2,634,000 after acquiring an additional 1,391 shares during the last quarter. UniSuper Management Pty Ltd boosted its position in Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock valued at $34,954,000 after acquiring an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new stake in Danaher during the first quarter valued at $539,000. Finally, Horizon Financial Services LLC boosted its position in Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock valued at $1,681,000 after acquiring an additional 8,160 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE DHR opened at $202.53 on Monday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41. The stock has a market cap of $145.02 billion, a price-to-earnings ratio of 43.09, a PEG ratio of 2.88 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The firm’s 50-day simple moving average is $200.66 and its 200 day simple moving average is $197.07.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same quarter last year, the firm earned $1.72 EPS. The firm’s revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Wall Street Analyst Weigh In

A number of brokerages have commented on DHR. Rothschild Redb cut shares of Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Wells Fargo & Company cut their price objective on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 23rd. Guggenheim reissued a “buy” rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, July 23rd. Finally, UBS Group cut their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $244.60.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.